- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 10, 2025 | 44.39M sh |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $429.08M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $404.23M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $50M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $165.11M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $286.5M |
| Current Assets | FY 2024 · Dec 31, 2023 | $316.92M |
| Total Assets | FY 2024 · Dec 31, 2023 | $673.64M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 42.03M sh |
| Capex restated | FY 2024 · Dec 31, 2022 | $13.1M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$28.45M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $160.13M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$18.02 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$18.02 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $217.4M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $216.36M |
| Net Income | FY 2024 · Dec 31, 2022 | −$757.48M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$749.43M |
| Revenue | FY 2024 · Dec 31, 2022 | $502.26M |